Entering text into the input field will update the search result below

Biosurgery Market: Size, Share, Growth, Emerging Trends, Top 10 Players And Industry Outlook

Dec. 07, 2021 12:39 AM ETBaxter International Inc. (BAX), JNJ, MDT, PFE, SYK, UK
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • In February 2020, Baxter announced 510 (k) clearance from US FDA for Peri-Strips Dry with Veritas Collagen Matrix product with Secure Grip.
  • In February 2020, Integra LifeSciences Holdings Corp. launched AmnioExcel Plus Placental Allograft Membrane for use across soft tissue repair.

This report aims to provide detailed insights into the global biosurgery market. It provides valuable information on the type, procedure, application, and region in the bio surgery market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Biosurgery Market Revenue Growth Analysis:

[392 Pages Report] The biosurgery market is projected to reach USD 16.0 billion by 2026 from USD 12.2 billion in 2021, at a CAGR of 5.7%.

Download PDF Brochure:

Biosurgery Market

Key Factors Driving Biosurgery Market Growth:

Rising focus towards effective blood loss management and growth in the volume of elective surgeries are driving the demand for biosurgery products. Increasing prevalence of lifestyle disorders and chronic diseases and rising geriatric population can be attributed to contribute towards an increase in elective surgical procedures globally. Moreover, increasing incidence of severe traumatic injuries is also driving the demand of biosurgery products as a substitute to alternative suture and ligature-based procedures. Vendors are using organic growth strategies such as product launches and innovations, which has resulted into an increasing availability of advanced products in bio surgery market globally.

Biosurgery Market (MarketsandMarkets)

Competitive Landscape:

The competitive landscape includes the analysis of the key growth strategies adopted by major players to expand their global presence and increase their shares in the market. The key growth strategies adopted by the top players in the market include product launches and approvals, agreements, expansions, and acquisitions. Product approvals and launches were the most widely adopted growth strategies by market players in the last three years to garner a larger share of the market.

Key Players:

  • Johnson & Johnson (US),
  • Baxter International Inc. (US),
  • Medtronic Plc (Ireland),
  • Becton, Dickinson & Co. (US),
  • B. Braun Melsungen AG (Germany),
  • Stryker Corp. (US),
  • Integra Lifesciences Holdings Corp. (US)

Get more crucial industry insights:


Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.